Peripheral nerve blockade for ambulatory surgery

Published on 27/02/2015 by admin

Filed under Anesthesiology

Last modified 27/02/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1180 times

CHAPTER 8 Peripheral nerve blockade for ambulatory surgery

Introduction

Over the last 15–20 years there has been a rapid increase worldwide in the numbers of surgical patients being treated in the ambulatory setting. While the main driving force has been a financial one, there are many benefits for patients including faster return home, greater access to treatment, and innovations in both anesthetic and surgical techniques to facilitate the rapid discharge of patients from hospital.1

Anesthesia provided in the ambulatory setting must be such that the patient is rapidly awake, has minimal postoperative cognitive dysfunction, mild or no pain, a very low risk (<15%) of postoperative nausea and/or vomiting (PONV), is able to commence oral diet within a few hours and is able to ambulate with minimal support (apart from an aid such as a crutch). The ability to void urine is not a requirement unless neuraxial anesthesia has been performed or the patient has undergone a surgical procedure likely to lead to urinary retention. These parameters are necessary in order to avoid unplanned hospital admissions (Box 8.1).

These post-anesthesia attributes will already be familiar to anesthesiologists who practice regional anesthesia and therefore it is logical that there is a significant role for the use of peripheral nerve blocks (PNB) for ambulatory surgery. This chapter will provide the reader with a comprehensive overview of the use of PNB for ambulatory surgery.

There are four main sections to the chapter. The first section will detail the practical matters of setting up and running an ambulatory PNB service; the final section will expand on the role and management of catheters and continuous infusions; the second and third sections will discuss specific points in relation to what blocks to use for what type of surgery for the upper and lower limbs respectively.

Setting up and running a peripheral nerve blockade service in an ambulatory setting

The starting up and running of a successful PNB service in an ambulatory setting requires consideration of a number of areas,2 which are described in the following paragraphs (Box 8.2).

Performance of techniques

Proper preparation is vital for the safe provision of regional anesthesia and this is discussed in greater detail in another chapter of this book. Briefly, the following equipment and drugs are required (Box 8.3) and we would recommend that a dedicated regional anesthesia trolley be organized. Importantly, Intralipid must be stored as part of the emergency drugs.

Although the successful use of Intralipid for LA toxicity in humans has only been documented in case reports, the results have been so dramatic that its use is recommended. Intralipid has been effective in LA toxicity resulting from the long-acting amides bupivacaine, ropivacaine and levobupivacaine. While successful use has been described for the short-acting LA, mepivacaine, to date the only use for lidocaine has been in a pediatric patient who received both lidocaine and ropivacaine for psoas compartment block.6

The individual nerve block techniques are described in detail in their respective chapters. The type of block to choose for a particular surgical procedure is discussed in the relevant upper or lower limb section.

Modern peripheral nerve blockade is performed using either a nerve-stimulation technique (NST) or ultrasound guidance (USG) to locate the relevant nerves. USG for PNB is generally accepted to result in a faster onset (about 5 minutes), higher success rates (3–10% greater when compared to multi-stimulation techniques) and possibly lower LA volumes compared to NST.7,8 However, whether these differences will result in benefit in the average ambulatory setting is debatable. The advantage of USG may be offset by its significantly increased capital cost.

Sedation has potential advantages and disadvantages. Disadvantages are mainly related to excessive sedation or loss of the airway. Advantages of sedation include a reduction in patient anxiety, increased comfort during prolonged (>1 hour) surgery and improved patient cooperation during block performance. The choice of sedation is one for each anesthesiologist, but in our experience in the ambulatory setting intravenous midazolam often negates the benefits of a PNB technique, and either low doses of fentanyl, alfentanil or propofol result in patient comfort and controlled sedation. For longer surgery, a low dose target-controlled infusion of propofol (1–2 µg/mL) is an alternative. However, continuous monitoring of respiratory effort and oxygen saturation is necessary.

Choice of local anesthetic

The main determinant of the type of LA to use is the duration of surgery. In reality, the duration of the shorter acting LAs such as the ester prilocaine (3–4 mg/kg), or amides lidocaine (4.5 mg/kg) and mepivacaine (5–6 mg/kg) is sufficient for most ambulatory surgery. The addition of epinephrine (1 : 200 000) prolongs the duration of action of lidocaine from 1–1.5 hours to 3.5–4 hours, which is equivalent to mepivacaine. Adding epinephrine also increases the permitted dose of lidocaine to 7 mg/kg.

Other adjuncts can be added – tramadol prolongs mepivacaine and clonidine increases block duration for both lidocaine and mepivacaine. Unfortunately, the doses of clonidine (2 µg/kg) required often result in sedation, which may be undesirable in a day surgery setting and delay discharge.

Long-acting LAs such as levobupivacaine and ropivacaine are generally not used because of the prolonged motor blockade. The use of a continuous technique allows lower doses to be used, providing a motor sparing effect, and is useful for more major ambulatory surgery such as shoulder arthroplasty.9 There are no studies in the ambulatory setting comparing the duration of analgesia of long- versus short-acting LAs, but it is reasonable to assume that the benefits seen with long-acting LAs for in patients would be similar. Performing selective analgesic blocks with a long-acting LA while using a short-acting LA for the main block and anesthesia, is an effective technique (for example, for a Dupuytren’s contracture, performing an axillary block with mepivacaine and an ulnar block at the elbow with levobupivacaine).

Postoperative care

The postoperative management of patients who receive a PNB in an ambulatory setting is particularly important, as they will be discharged relatively earlier from the healthcare facility.

Although there has been some debate regarding the feasibility and safety of discharging a patient home with an insensate limb, general consensus is that patients can be discharged if some basic principles are followed.

Firstly, the anesthesiologist has to be prepared to accept the clinical situation. Even with short-acting LAs, 50% of patients will have residual block present when they are otherwise fit for discharge home.10 The discharge criteria normally used for patients undergoing GA, such as the modified Aldrete score, are inappropriate because they require the patient to move all four limbs.11 A scoring system not requiring limb movement, such as the Postanesthesia discharge scoring system (PADSS), may have to be incorporated into your practice12 (Table 8.1).

Table 8.1 Post-anesthesia discharge scoring system (PADSS) for determining home readiness

Discharge criteria Score
Vital signs:  
Vital signs must be stable and consistent with age and pre-operative baseline  
Blood pressure and pulse within 20% of pre-operative baseline 2
Blood pressure and pulse 20–40% of pre-operative baseline 1
Blood pressure and pulse >40% of pre-operative baseline 0
Activity level:  
Patient must be able to ambulate at pre-operative level  
Steady gait, no dizziness, or meets pre-operative level 2
Requires assistance 1
Unable to ambulate 0
Nausea and vomiting:  
Patient should have minimal nausea and vomiting before discharge  
Minimal: successfully treated 2
Moderate: successfully treated with intravenous medication 1
Severe: continues after repeated treatment 0
Pain:  
Patient should have minimal or no pain before discharge  
The level of pain that the patient has should be acceptable to the patient  
Pain should be controllable by oral analgesics  
The location, type and intensity of pain should be consistent with anticipated postoperative discomfort  
Pain acceptable 2
Pain controllable with oral analgesics 1
Pain not acceptable 0
Surgical bleeding:  
Postoperative bleeding should be consistent with expected blood loss for the procedure  
Minimal: does not require dressing change 2
Moderate: up to two dressing changes required 1
Severe: more than three dressing changes required 0
TOTAL  

Maximum score = 10.

Patients scoring ≥ 9 are fit for discharge.

Modified after Chung F, Chan VW, Ong D. J Clin Anesth 1995;7(6):500–6.

Buy Membership for Anesthesiology Category to continue reading. Learn more here